Arthritis Pain gateway features information on dealing with chronic pain. Understanding Your Pain. Managing Your Pain.
Latest Articles
Juvenille Rheumatoid ArthritisRheumatoid arthritis is a disease that attacks the joints in the body, causing inflammation and pain. It can affect anyone at any age. Children are no exception to rheumatoid arthritis. In children, this chronic disease is called as juvenile...
Rheumatoid Arthritis - What Is It?
What is rheumatoid arthritis? Rheumatoid arthritis is a chronic inflammation of multiple joints in the body with predilection for smaller joints in the hands. Rheumatoid arthritis causes signs and symptoms of inflammation in joints that include...
Treating dog arthritis with natural supplements.
Dog arthritis is one of the most common diseases that affect canines; especially large breed dogs (60-90 lbs) the best thing you can do is to prevent the occurrence of this disease with the appropriate supplements when your dog is 4 or 5 years old...
Glucosamine: New Hope for Thousands of Arthritis Sufferers
Initial Results of National Institutes of Health (NIH) Funded Study Reveal Glucosamine and Chondroitin Effective in Treating Moderate to Severe Osteoarthritis Knee Pain.
Findings Bring New Hope for Millions of Americans Suffering from Arthritis For 21 million Americans hobbled by osteoarthritis, new science confirms nutritional supplements glucosamine and chondroitin are the right combination for effective knee pain relief. The Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT), funded by NIH, rigorously evaluated the efficacy and safety of glucosamine and chondroitin in 1,258 people, concluding in its abstract that the "combination of glucosamine and chondroitin sulfate is effective in treating moderate to severe knee pain due to osteoarthritis."
GAIT lead researcher Daniel O. Clegg, M.D., Professor of Medicine and Chief of Rheumatology at the University of Utah, will present findings from the full study on November 14, 2005 at the American College of Rheumatology's Scientific Meeting in San Diego, California.
"GAIT brings good news to adults suffering from the wear and tear of cartilage degeneration, particularly those who cannot tolerate the side effects of taking nonsteroidal anti-inflammatory drugs (NSAIDs)," said C. Thomas Vangsness, Jr., MD, Professor Orthopaedic Surgery, Keck School of Medicine, University of Southern California. "For years glucosamine and chondroitin have been well recognized alternative solutions to pharmaceutical options in treating osteoarthritis patients in Europe, Asia and Russia. In fact, preliminary results reported in the GAIT abstract indicated glucosamine and chondroitin were found to be more effective than Celebrex® in treating moderate to severe knee pain. Clearly, the GAIT abstract suggests glucosamine and chondroitin together may be a good non-surgical pain relief choice for arthritis patients," added Dr. Vangsness.
Funded by NIH, the $14 million GAIT study is the largest placebo controlled, double blind, clinical trial ever conducted to test the effectiveness of
glucosamine and chondroitin. All 1,258 patients who completed the study were over the age of 40 with knee pain and randomly assigned placebo; glucosamine 1500 mg; chondroitin 1200mg; glucosamine/chondroitin at above mentioned doses; or celecoxib (Celebrex) 200 mg daily for 6 months. The abstract published each treatment group's response rate to pain. Of note, the group taking the glucosamine/chondroitin combination experienced greater relief for the treatment of moderate to severe knee pain than the Celebrex group.
GAIT was designed to test the safety and efficacy of glucosamine and chondroitin alone and in combination in reducing knee pain associated with osteoarthritis. The study's abstract concluded that when taken together, "glucosamine and chondroitin is effective in treating moderate to severe knee pain due to OA [osteoarthritis]."
Naturally occurring in the body, glucosamine stimulates the production of cartilage, the connective tissue which cushions joints. Chondroitin is also naturally occurring in the body and like glucosamine stimulates the production of cartilage. Previous research indicates glucosamine is just as effective as non-steroidal anti-inflammatory drugs (NSAIDs) in reducing osteoarthritis pain and has fewer gastrointestinal side effects than NSAIDs.
Nearly 1 in 3 Americans (nearly 70 million) live with some form of arthritis, costing the United States $82.5 billion a year in healthcare costs related to treating the illness.(2) For arthritis knee pain sufferers who find relief in taking glucosamine and chondroitin, they will also find the supplements to be great values. Widely used in Europe for years to treat osteoarthritis, glucosamine and chondroitin are safe and effective nutritional supplements, as proven by the GAIT abstract.
As an Arthritis sufferer I pleased that Glucosamine is getting the recognition it deserves, for more information on how glucosamine helped me and how it can help you go to http://www.beatyourarthritis.com
Written By: J Hall
People's Pharmacy: Supplement for arthritis raised cholesterol - Tuscaloosa News
studies do not demonstrate any benefits for mild to moderate ... My 15-year-old son had low HDL and a poor cholesterol profile at his checkup. (Total cholesterol was 146, HDL 29 and LDL 96). So for 10 months,
Rheumatoid Arthritis Signaling Protein GM-CSF Reverses Alzheimer's Disease In Mouse ... - Medical News Today
A signaling protein released during rheumatoid arthritis dramatically reduced Alzheimer's disease pathology and reversed the memory impairment of mice bred to develop symptoms of the neurodegenerative disease ...
Disease Activity Is Main Factor in Disability from Rheumatoid Arthritis - Newswise
Source: Wolters Kluwer Health: Lippincott Williams & Wilkins Newswise — For people living with rheumatoid arthritis (RA), the level of disease activity—measured using the standard DAS 28 score—is the factor most ...
Chelsea Therapeutics' experimental rheumatoid arthritis drug trial gets FDA nod - Small Cap Network
As we told our readers last Friday, Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) was set to run higher in anticipation of FDA news. This morning, the company has announced that the U.S. Food and ...
Chelsea Therapeutics gets FDA OK to start study - Forbes
CHARLOTTE, N.C. -- Chelsea Therapeutics International Ltd. said Thursday it received Food and Drug Administration clearance to start a midstage study on a potential rheumatoid arthritis drug. The company said ...
Celebrex Appears Easier on Stomach for Arthritis Patients - MedicineNet.com
THURSDAY, June 17 (HealthDay News) -- Patients who take the painkiller celecoxib for arthritis pain and inflammation are less likely to suffer gastrointestinal damage than those who take diclofenac plus omeprazole , a ...
Arthritis: The Secret to Treating Alzheimer's? - Redorbit.com
(Ivanhoe Newswire) -- Researchers know that people with rheumatoid arthritis are less likely to develop Alzheimer's disease. Now, they may have an explanation why. A new study shows a protein released in ...
